Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virological response
Brian L. Pearlman, Carole EhlebenVolume:
52
Year:
2010
Language:
english
Pages:
2
DOI:
10.1002/hep.23925
File:
PDF, 271 KB
english, 2010